Jason White

13PUBLICATIONS
91CO-AUTHORS
Predictive and prognostic markersChemotherapyMolecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 19, 2026
Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study results.

Rashmi K Murthy, Barbara J O'Brien, Donald A Berry

|Dec 18, 2025
Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.

Beatriz E Adrada, Mary S Guirguis, Lei Huo

|Aug 13, 2025
An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy.

Amanda L Rinkenbaugh, Yuan Qi, Shirong Cai

|Oct 02, 2024
Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study.

Clinton Yam, Miral Patel, Holly A Hill

|Mar 14, 2024
Comprehensive Analysis Identifies Variability in PI3K Pathway Alterations in Triple-Negative Breast Cancer Subtypes.

Reva K Basho, Li Zhao, Jason B White

|Jan 10, 2023
Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer.

Gloria V Echeverria, Shirong Cai, Yizheng Tu

Pageof 3

Frequent Collaborators

6 joint publications

Gaiane M Rauch

6 joint publications

Debu Tripathy

6 joint publications

Jeffrey T Chang

5 joint publications

Jennifer Litton